Exelixis (EXEL) Tops Q2 EPS by 30c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Exelixis (EXEL) Tops Q2 EPS by 30c

Exelixis Announces Second Quarter 2021 Financial Results and Provides Corporate Update

August 5, 2021 4:05 PM EDT

- Total Revenues of $385.2 Million, Cabozantinib Franchise Revenues of $284.2 Million -

- GAAP Diluted EPS of $0.30, Non-GAAP Diluted EPS of $0.37 -

- Raised Net Product Revenue Guidance to $1,050 - $1,150 Million and Total Revenue Guidance to $1,300 - $1,400 Million -

- Conference Call and Webcast Today at 5:00 PM Eastern Time -

ALAMEDA, Calif.--(BUSINESS WIRE)-- Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the second quarter of 2021 and provided an update on progress... More